New Insights in Thoracic Sarcoma
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 1403
Special Issue Editor
Special Issue Information
Dear Colleagues,
Sarcomas are rare cancers deriving from mesenchymal cells and include over one hundred different histologic entities. Sarcoma may involve any structure throughout the body. Despite their rarity, Surgeons, Medical or Radiation Oncologists, Radiologists and Respirologists dealing with Thoracic Oncology will invariably encounter Thoracic Sarcomas as primary or secondary lesions. Primary thoracic sarcoma most commonly involve the chest wall, pleura, mediastinum and lung. Secondary lesions are most commonly seen in the pleura (pleural sarcomatosis) or in the pulmonary parenchyma. Awareness and identification of these rare entities as well as adequate diagnosis and treatment are of paramount importance for optimal outcome.
We are pleased to invite you to participate in this Special Issue covering relevant aspects of Thoracic Sarcoma from diagnosis to treatment. Current as well as future therapies will also be discussed.
This Special Issue aims to
- Describe the features and treatment of thoracic sarcomas based on their anatomic location: lung, pulmonary artery, mediastinum and chest wall.
- Discuss the potential of systemic treatment for thoracic sarcoma, applied locally (in-vivo lung perfusion-IVLP, Hyperthermic Intrathoracic Chemotherapy –HITOC).
- Discuss future systemic treatment beyond chemotherapy.
In this Special Issue, original research articles and reviews are welcome.
Prof. Dr. Stéphane Collaud
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- thoracic sarcoma
- surgery
- lung
- chest wall
- pleura
- mediastinum
- pulmonary artery
- en bloc resection
- chemotherapy
- hyperthermic intrathoracic chemotherapy
- HITOC
- lung perfusion
- IVLP
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
